Original Source(s)
Related Content
TOFA may drive weight loss without reducing food intake
The oral compound increased energy expenditure, reduced fat mass, and improved metabolic measures in male mouse models.
August 27, 2026
-
4 min
FDA Approves New Treatment for Thyroid Eye Disease
Phase 3 THRIVE and THRIVE-2 trials supported approval following improvements in proptosis and diplopia in active and chronic disease.
June 29, 2026
-
3 min
Tirzepatide’s cardiovascular effects in clinical practice
Investigators compared cardiovascular outcomes with tirzepatide and a placebo proxy in patients with type 2 diabetes and established atherosclerotic cardiovascular disease.
August 28, 2026
-
4 min